By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – NeoProteomics announced on Tuesday it has been awarded a two-year, $300,000 grant from the National Institutes of Health to develop software for commercial applications.

The Small Business Innovation Research grant will be used by the Cleveland-based protein biomarker development and software firm to develop applications for four software programs that it has licensed from Case Western Reserve University, from which NeoProteomics was spun out in 2006.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The apple has traveled westward and eastward along the Silk Road, according to a new genetic analysis.

In Nature this week: GWAS data used to reposition drugs for psychiatric use, and more.

Genetic disease risk information doesn't always spur people to make healthy lifestyle changes, according to the Associated Press.

A University of California, San Diego-led team has used liquid biopsies to uncover possible treatments for patients with cancers of unknown primary.